Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich, US Genomics

Premium

Sigma-Aldrich recently announced that it has released new additions to its Mission TRC RNAi product line. These additions bring the current number of vector constructs offered to 50,000, targeting 7,100 human and 2,900 mouse genes, the company said.

The constructs are available as frozen bacterial glycerol stocks or transfection grade plasmid DNA, Sigma-Aldrich said.

Additional information about the Mission RNAi products can be found at http://www.sigmaaldrich.com/Area_of_Interest/Life_Science/RNA_Interference_RNAi.html.


US Genomics has recently unveiled its Direct Results fee-for-service program, which allows researchers to use single molecule technology to accurately quantitate the microRNAs in their samples.

According to the company, the new service uses the Trilogy 2020 single molecule analyzer to enable scientists to detect individual molecules of miRNA with Direct miRNA assays.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.